In analogy to the hypothesis in Figure 5, we hypothesized that presentation of α-gal epitopes on tumor cells of individual patients will result in binding of anti-Gal to these epitopes as a “universal” enhancer of vaccine immunogenicity (LaTemple et al., 1996; Galili and LaTemple, 1997). The gene discussed is GAL; the disease is neoplasm.